Bilateral optic nerve sheath fenestration is associated with significant improvement in papilledema and visual function for patients with idiopathic intracranial hypertension.
Read the full answer →
Optic nerve sheath fenestration (ONSF) improves vision and reduces swelling in many patients with idiopathic intracranial hypertension, especially when other treatments fail.
Read the full answer →
Urgent venous sinus stenting can rapidly improve vision and reduce pressure in fulminant idiopathic intracranial hypertension, but success depends on acting before permanent optic nerve damage occurs.
Read the full answer →
Yes, unilateral selective laser trabeculoplasty (SLT) can lower IOP in the untreated eye, with a mean reduction of about 1.85 mmHg at 3-6 months.
Read the full answer →
Yes, a systematic review found significant regional differences in hypertension rates among HS patients, with North America having higher odds than the Middle East/Asia.
Read the full answer →